lisuride has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horowski, R; Jähnig, P; Jenner, P; Lange, KW; Löschmann, PA; Marsden, CD; Wachtel, H | 1 |
| Kunow, M; Löschmann, PA; Wachtel, H | 1 |
| Kito, S; Matsubayashi, H; Miyoshi, R; Mizuno, K; Nitta, K; Tahara, E; Yamamura, Y | 1 |
| Bankiewicz, K; Brücke, T; Harvey-White, J; Kopin, I | 1 |
| Fukuda, T; Irifune, M; Iwata, S; Kaseda, S; Nomoto, M; Osame, M | 1 |
5 other study(ies) available for lisuride and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Callithrix; Disease Models, Animal; Dopamine Agents; Female; Lisuride; Male; Motor Activity; Parkinson Disease, Secondary; Time Factors | 1992 |
Synergism of NBQX with dopamine agonists in the 6-OHDA rat model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Drug Synergism; Lisuride; Male; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Quinoxalines; Rats; Rats, Wistar; Stereotaxic Techniques; Substantia Nigra | 1992 |
Autoradiographic distributions of neurotransmitter receptors in the human brains of Parkinson's disease and primate models of MPTP-induced parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain; Humans; Lisuride; Macaca; Neurotransmitter Agents; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Quinuclidinyl Benzilate; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Neurotransmitter | 1987 |
The partial dopamine receptor agonist terguride in the MPTP-induced hemiparkinsonian monkey model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Ergolines; Female; Lisuride; Macaca fascicularis; Parkinson Disease, Secondary; Pyridines; Receptors, Dopamine | 1988 |
[Dermal application of lisuride on parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset and on cases with Parkinson's disease].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Cutaneous; Aged; Animals; Antiparkinson Agents; Callithrix; Circadian Rhythm; Disease Models, Animal; Dopamine Agonists; Female; Humans; Lisuride; Male; Middle Aged; Motor Activity; Parkinson Disease; Parkinson Disease, Secondary; Time Factors; Treatment Outcome | 1998 |